Oncolytics Biotech Signs Agreement To Offer, Sell Up To $75M Common Stock

Benzinga Newsdesk www.benzinga.com Neutral 92.6%

Neg 0% Neu 92.6% Pos 0%

https://www.sec.gov/ix?doc=/Archives/edgar/data/1129928/000110465926039935/tm2610715d2_8k.htm

Comments

No comments yet. Be the first!